secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001522767-23-000075
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q1 revenue up 10% YoY to $34.4M but GAAP net loss of $0.7M vs prior-year profit
--------------------------------------------------------------------------------

- Revenue $34.4M vs $31.3M YoY (+10%); GAAP gross margin fell to 45% from 54%.
- GAAP net loss $(0.7)M vs net income $4.2M a year ago; non-GAAP net income $0.3M.
- Adjusted EBITDA $7.1M (21% margin) down from $10.4M (33% margin) in Q1 2022.
- CEO notes 13th consecutive quarter of positive adjusted EBITDA; expects 4th straight year of positive operating cash flow.
- Non-GAAP adjusted EBITDA margin declined to 21% from 33% on higher costs and product mix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000075/0001522767-23-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000075/mrmd-20230508.htm
  HTML page:      https://secwatch.observer/filing/0001522767-23-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer